Skip to main navigation Skip to search Skip to main content

Correction: YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer (Oncogene, (2021), 40, 13, (2407-2421), 10.1038/s41388-021-01718-4)

Research output: Contribution to journalComment/debatepeer-review

Abstract

Unfortunately, the institute name by affiliation 2 was given incorrect. The correct name is: Department of Urology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan Corresponding author of the paper is Shih-Chieh Lin [email protected] The original article has been corrected.

Original languageEnglish
Pages (from-to)4060
Number of pages1
JournalOncogene
Volume40
Issue number23
DOIs
Publication statusPublished - 2021 Jun 10

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction: YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer (Oncogene, (2021), 40, 13, (2407-2421), 10.1038/s41388-021-01718-4)'. Together they form a unique fingerprint.

Cite this